0.00
price down icon100.00%   -0.1815
after-market Handel nachbörslich: .17 0.17 +
loading
Schlusskurs vom Vortag:
$0.1815
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$2.13M
Einnahmen:
$19.91M
Nettoeinkommen (Verlust:
$-127.11M
KGV:
0.00
EPS:
-8.428
Netto-Cashflow:
$-132.44M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$4.505

Affimed N V Stock (AFMD) Company Profile

Name
Firmenname
Affimed N V
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
78
Name
Twitter
@affimed
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
AFMD's Discussions on Twitter

Vergleichen Sie AFMD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AFMD
Affimed N V
0.00 2.13M 19.91M -127.11M -132.44M -8.428
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
387.18 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.65 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.20 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
708.09 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
308.91 37.96B 3.81B -644.79M -669.77M -6.24

Affimed N V Stock (AFMD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-14 Herabstufung H.C. Wainwright Buy → Neutral
2025-05-13 Herabstufung Leerink Partners Outperform → Market Perform
2022-12-12 Eingeleitet H.C. Wainwright Buy
2022-10-10 Herabstufung Stifel Buy → Hold
2022-08-18 Fortgesetzt Wells Fargo Overweight
2022-03-31 Eingeleitet Piper Sandler Overweight
2022-02-23 Eingeleitet Cantor Fitzgerald Overweight
2021-10-21 Eingeleitet Truist Buy
2021-09-30 Eingeleitet Stifel Buy
2021-03-31 Eingeleitet Credit Suisse Outperform
2019-03-28 Eingeleitet SVB Leerink Outperform
2018-08-28 Hochstufung Jefferies Hold → Buy
2017-07-14 Eingeleitet SunTrust Buy
2016-08-12 Herabstufung Leerink Partners Outperform → Mkt Perform
2016-05-19 Herabstufung Leerink Partners Outperform → Mkt Perform
2015-12-10 Eingeleitet Laidlaw Buy
2015-12-04 Eingeleitet Wells Fargo Outperform
2015-09-09 Eingeleitet Jefferies Hold
2015-08-06 Bestätigt Oppenheimer Outperform
2015-06-22 Bestätigt Jefferies Buy
Alle ansehen

Affimed N V Aktie (AFMD) Neueste Nachrichten

pulisher
Aug 20, 2025

What earnings revisions data tells us about Affimed N.V.July 2025 Opening Moves & Short-Term High Return Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Automated trading signals detected on Affimed N.V.2025 Retail Activity & High Return Stock Watch Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Price momentum metrics for Affimed N.V. explainedJuly 2025 Highlights & Entry Point Confirmation Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What MACD and RSI say about Affimed N.V.Chart Signals & Comprehensive Market Scan Reports - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

How to build a dashboard for Affimed N.V. stockLong Setup & Fast Entry and Exit Trade Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Intraday pattern recognizer results for Affimed N.V.2025 Price Targets & Smart Allocation Stock Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Sentiment analysis tools applied to Affimed N.V.2025 Top Gainers & Fast Entry Momentum Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Affimed N.V. stock outlook for YEAR2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Forecasting Affimed N.V. price range with options data2025 Biggest Moves & Free Safe Capital Growth Stock Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How to recover losses in Affimed N.V. stockWeekly Profit Analysis & AI Enhanced Trading Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Heatmap analysis for Affimed N.V. and competitorsGap Down & Risk Adjusted Buy and Sell Alerts - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Why Affimed N.V. stock attracts strong analyst attentionJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

How Affimed N.V. stock performs during market volatilityJuly 2025 Institutional & Momentum Based Trading Signals - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Real time breakdown of Affimed N.V. stock performance2025 Price Targets & Expert Curated Trade Setup Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Ranking Affimed N.V. among high performing stocks via toolsWeekly Market Summary & Real-Time Volume Triggers - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Price action breakdown for Affimed N.V.Weekly Investment Recap & Intraday High Probability Setup Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Affimed N.V. exposed to currency risksMarket Performance Recap & Community Verified Watchlist Alerts - thegnnews.com

Aug 16, 2025
pulisher
Aug 15, 2025

Has Affimed N.V. Stock Ever Crashed Historical Volatility Review2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Will Affimed N.V. benefit from current market trendsJuly 2025 Pullbacks & Consistent Profit Focused Trading Strategies - newsyoung.net

Aug 15, 2025
pulisher
Aug 15, 2025

How to forecast Affimed N.V. trends using time seriesPortfolio Value Summary & AI Enhanced Market Trend Forecasts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Price Action Confirms Reversal in Affimed N.V. TrendJuly 2025 Pullbacks & Long-Term Investment Growth Plans - beatles.ru

Aug 15, 2025
pulisher
Aug 14, 2025

Using RSI to spot recovery in Affimed N.V.July 2025 Summary & Technical Pattern Based Buy Signals - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Sector ETF Data Correlates with Strength in Affimed N.V.Weekly Trade Report & Capital Protection Trade Alerts - newsyoung.net

Aug 14, 2025
pulisher
Aug 13, 2025

Order Book Volume Tilts Bullish on Affimed N.V.Gap Down & Daily Entry Point Alerts - beatles.ru

Aug 13, 2025

Finanzdaten der Affimed N V-Aktie (AFMD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Kapitalisierung:     |  Volumen (24h):